Orphazyme A/S
CSE:ORPHA

Watchlist Manager
Orphazyme A/S Logo
Orphazyme A/S
CSE:ORPHA
Watchlist
Price: 850 DKK 1.19%
Market Cap: 34m DKK

Wall Street
Price Targets

ORPHA Price Targets Summary
Orphazyme A/S

There are no price targets for ORPHA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Orphazyme A/S Competitors:
Price Targets
COV
Covalon Technologies Ltd
72% Upside
BAVA
Bavarian Nordic A/S
35% Upside
XGN
Exagen Inc
149% Upside
688266
Suzhou Zelgen Biopharmaceuticals Co Ltd
47% Upside
1530
3SBio Inc
49% Upside
PRQR
ProQR Therapeutics NV
342% Upside
301047
Sino Biological Inc
19% Upside
SPRY
ARS Pharmaceuticals Inc
157% Upside

Revenue
Forecast

Revenue Estimate
Orphazyme A/S

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Orphazyme A/S

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
Orphazyme A/S

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ORPHA's stock price target?
Not Available

ORPHA doesn't have any price targets made by Wall Street professionals.

Back to Top